Dongbang Medical Co. Ltd. (240550) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Dongbang Medical Co. Ltd. (240550:KRX), powered by AI.

Current Price
₩6,300
P/E Ratio
39.3
Market Cap
131.1B
Sector
Common Stock
What is the Dongbang Medical Co. Ltd. stock price forecast?

Dongbang Medical Co. Ltd. is currently trading at ₩6,300. View real-time AI analysis on Alpha Lenz.

What is Dongbang Medical Co. Ltd. insider trading activity?

View the latest insider trading data for Dongbang Medical Co. Ltd. on Alpha Lenz.

What is Dongbang Medical Co. Ltd.'s P/E ratio?

Dongbang Medical Co. Ltd.'s P/E ratio is 39.3.

Dongbang Medical Co. Ltd.

₩6.30K
KRX240550
Ask about Dongbang Medical Co. Ltd.'s future dividend policy...
Alpha Chat Insight

Dongbang Medical Co. Ltd. trades at a P/E of 39.3 (premium valuation) with modest ROE of 4.2%.

Ask for details

Company Overview

Dongbang Medical Co. Ltd. is a prominent player in the healthcare equipment sector, known for developing and distributing medical devices and supplies. The company's primary focus is on providing advanced medical tools that cater to a variety of medical practices, including specialized equipment for diagnostics and therapeutic procedures. Dongbang Medical's product portfolio is instrumental in enhancing healthcare services across hospitals, clinics, and other medical institutions. With a commitment to innovation, the company continually seeks to improve the efficacy and safety of its medical products. Market significance lies in its ability to meet the growing demand for high-quality medical equipment which is crucial in advancing patient care and supporting healthcare professionals. The company's activities reflect broader trends in the healthcare industry, such as the increasing emphasis on technological integration and enhanced patient outcomes.

CEO김근식
SectorCommon Stock
IndustryCommon Stock
Employees269

Company Statistics

(FY 2024)

Profile

Market Cap₩131.10B
Revenue₩105.11B
Shares Out20.81M
Employees269

Margins

Gross32.55%
EBITDAN/A
Operating14.31%
Pre-Tax6.46%
Net2.97%

Valuation

P/E39.25
P/B1.64
EV/Sales1.25
EV/EBITDA7.75
P/FCFN/A

Growth (CAGR)

Rev 3YrN/A
Rev 5YrN/A
Op Inc 3YrN/A
Op Inc 5YrN/A
Net Inc 3YrN/A
Net Inc 5YrN/A

Returns

ROA2.08%
ROE4.18%
ROIC10.01%

Financial Health

Cash & Cash Equivalents₩15.37B
Net Debt₩54.28B
Debt/Equity86.30%
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Dongbang Medical Co. Ltd. (Common Stock) Stock Forecast & Analysis ₩6,300 | Alpha Lenz